CFU-Hill Liquid Medium Kit (Human)

? 1.800.667.0322   > Contact Us

Medium for CFU-Hill Assay



  • CFU-Hill Medium Kit (Human)
  • Label for CFU-Hill Basal Medium 80 mL
  • Vial label for CFU-Hill Medium Supplements 20 mL
CFU-Hill Medium Kit (Human)
The CFU-Hill Liquid Medium Kit was previously named EndoCult®. The name was changed to accurately reflect the application of this product.
 
Components of the CFU-Hill Liquid Medium Kit have been pre-screened and performance tested for the generation and qualification of CFU-Hill colonies derived from human peripheral blood mononuclear cells. This product contains two components a) CFU-Hill Basal Medium (Human) and b) CFU-Hill Proliferation Supplement (Human).
Product Name Description Catalog # Size Price Quantity
CFU-Hill Liquid Medium Kit (Human) Medium for CFU-Hill assay 05900 1 Kit 340.00 USD      
 Save Item
CFU-Hill Liquid Medium Kit (Human) Medium for CFU-Hill assay 05950 5 Kits 1527.00 USD      
 Save Item

Order Offline:

Call us: +1.604.877.0713  
Toll Free: 1.800.667.0322  
Email us:
 
Fax us: +1.604.877.0704
Toll Free Fax: 1.800.567.2899

Recommended for:
The generation and quantification of CFU-Hill colonies from human peripheral blood
Components:
• CFU-Hill Basal Medium (Human), 80mL
• CFU-Hill Proliferation Supplement (Human), 20mL
Intended Use Statement: For Research Use Only. Not for Therapeutic or Diagnostic Use.
Contains:
CFU-Hill Liquid Medium Formulation is proprietary
Product Type: Specialized cell culture media
Application: Colony assays & quantification
Area of Interest: Angiogenic cell research, Stem cell biology
Cell Type: Angiogenic cells, Hematopoietic stem & progenitor cells, Monocytes, T cells
Popular Product Line: CFU-Hill Medium
Species: Human

This product has been used in:

  1. Gurnaam Kasbia et al. Reduced hemoglobin on day of peripheral blood progenitor cell collection is associated with low graft content of vascular progenitors and increased toxicity after autologous hematopoietic stem cell transplantation.Transfusion 48 (11) 2421-2428 (November 2008)
  2. Tariq Iqbal et al. Increased graft content of vascular progenitor cells is associated with reduced toxicity following autologous hematopoietic transplantation.Exp Hematol 36 (4) 506-512 (April 2008)
  3. Kazuho Shimura et al. Circulating endothelial progenitor cells decreased in patients with sclerodermatous chronic graft-versus-host disease.Biol Blood Marrow Transplant 14 (4) 426-437 (April 2008)
  4. Rachel T van Beem et al. The presence of activated CD4(+) T cells is essential for the formation of colony-forming unit-endothelial cells by CD14(+) cells.J Immunol 180 (7) 5141-5148 (April 1, 2008)
  5. Emeline M. F. Van Craenenbroeck et al. A maximal exercise bout increases the number of circulating CD34+/KDR+ endothelial progenitor cells in healthy subjects. Relation with lipid profile.J Appl Physiol 104 (4) 1006-1013 (April 1, 2008)
  6. Thomas Thum et al. Growth hormone treatment improves markers of systemic nitric oxide bioavailability via insulin-like growth factor-I.J Clin Endocrinol Metab 92 (11) 4172-4179 (November 2007)
  7. Patrizio Sarto et al. Effects of exercise training on endothelial progenitor cells in patients with chronic heart failure.J Card Fail 13 (9) 701-708 (November 2007)
  8. Mihail Hristov et al. Reduced numbers of circulating endothelial progenitor cells in patients with coronary artery disease associated with long-term statin treatment.Atherosclerosis 192 (2) 413-420 (June 2007)
  9. Kyung-Hee Chang et al. IGF binding protein-3 regulates hematopoietic stem cell and endothelial precursor cell function during vascular development.Proc Natl Acad Sci U S A 104 (25) 10595-10600 (June 19, 2007)
  10. Guido Krenning et al. Efficient differentiation of CD14+ monocytic cells into endothelial cells on degradable biomaterials.Biomaterials 28 (8) 1470-1479 (March 2007)
  11. Chao-Hung Wang et al. Pioglitazone increases the numbers and improves the functional capacity of endothelial progenitor cells in patients with diabetes mellitus.Am Heart J 152 (6) 1051.e1-8 (December 2006)
  12. Subhash Banerjee et al. Endothelial progenitor cell mobilization after percutaneous coronary intervention.Atherosclerosis 189 (1) 70-75 (November 2006)
  13. C Foresta et al. Reduced number of circulating endothelial progenitor cells in hypogonadal men.J Clin Endocrinol Metab 91 (11) 4599-4602 (November 2006)
  14. Thomas Thum et al. Bone marrow molecular alterations after myocardial infarction: Impact on endothelial progenitor cells.Cardiovasc Res 70 (1) 50-60 (April 1, 2006)
  15. P Palange et al. Circulating haemopoietic and endothelial progenitor cells are decreased in COPD.Eur Respir J 27 (3) 529-541 (March 2006)
  16. Rebecca Gusic Shaffer et al. Flow cytometric measurement of circulating endothelial cells: the effect of age and peripheral arterial disease on baseline levels of mature and progenitor populations.Cytometry B Clin Cytom 70 (2) 56-62 (March 2006)
  17. Eva Rohde et al. Blood monocytes mimic endothelial progenitor cells.Stem Cells 24 (2) 357-367 (February 2006)
  18. Mark S Segal et al. Nitric oxide cytoskeletal-induced alterations reverse the endothelial progenitor cell migratory defect associated with diabetes.Diabetes 55 (1) 102-109 (January 2006)
  19. Herbert Spring et al. Chemokines direct endothelial progenitors into tumor neovessels.Proc Natl Acad Sci U S A 102 (50) 18111-18116 (December 13, 2005)
  20. Thomas Thum et al. Suppression of endothelial progenitor cells in human coronary artery disease by the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine.J Am Coll Cardiol 46 (9) 1693-1701 (November 1, 2005)
  21. Elzafir Elsheikh et al. Only a specific subset of human peripheral-blood monocytes has endothelial-like functional capacity.Blood 106 (7) 2347-2355 (October 1, 2005)

Product Name

Description

Catalog #

Dulbecco's Phosphate Buffered Saline with 2% Fetal Bovine Serum Dulbecco's Phosphate Buffered Saline with 2% Fetal Bovine Serum 07905
Ficoll-Paque™ PLUS Density Gradient Medium for the Isolation of Mononuclear Cells 07907

CFU-Hill colony from human peripheral blood


CFU-Hill colony from human peripheral blood